Clinical and molecular findings in a cohort of ANO5-related myopathy

Detalhes bibliográficos
Autor(a) principal: Dourado Junior, Mário Emílio Teixeira
Data de Publicação: 2019
Outros Autores: Silva, André M. S., Coimbra-Neto, Antônio R.; et al.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRN
Texto Completo: https://repositorio.ufrn.br/handle/123456789/54227
https://doi.org/10.1002/acn3.50801
Resumo: Objective:ANO5-related myopathy is an important cause of limb-girdle muscu-lar dystrophy (LGMD) and hyperCKemia. The main descriptions have emergedfrom European cohorts, and the burden of the disease worldwide is unclear. Weprovide a detailed characterization of a large Brazilian cohort fANO5patients.Methods: A national cross-sectional study was conducted to describe clinical,histopathological, radiological, and molecular features of patients carrying reces-sive variants inANO5. Correlation of clinical and genetic characteristics with dif-ferent phenotypes was studied.Results: Thirty-seven patients from 34 nonrelatedfamilies with recessive mutations ofANO5were identified. The most commonphenotype was LGMD, observed in 25 (67.5%) patients, followed by pseu-dometabolic presentation in 7 (18.9%) patients, isolated asymptomatic hyperCK-emia in 4 (10.8%) patients, and distal myopathy in a single patient. Nine patientspresented axial involvement, including one patient with isolated axial weakness.The most affected muscles according to MRI were the semimembranosus and gas-trocnemius, but paraspinal and abdominal muscles, when studied, were involved in most patients. Fourteen variants inANO5were identified, and the c.191dupAwas present in 19 (56%) families. Sex, years of disease, and the presence of loss-of-function variants were not associated with specific phenotypes.Interpretation:We present the largest series of anoctaminopathy outside Europe. The most com-mon European founder mutation c.191dupA was very frequent in our population.Gender, disease duration, and genotype did not determine the phenotype.
id UFRN_d0bc84a1d9dfc9a72e438d77f20fe206
oai_identifier_str oai:https://repositorio.ufrn.br:123456789/54227
network_acronym_str UFRN
network_name_str Repositório Institucional da UFRN
repository_id_str
spelling Dourado Junior, Mário Emílio TeixeiraSilva, André M. S.Coimbra-Neto, Antônio R.; et al.https://orcid.org/0000-0002-9462-22942023-07-27T18:17:20Z2023-07-27T18:17:20Z2019DOURADO JUNIOR, Mário Emílio Teixeira, et al. Clinical and molecular findings in a cohort of ANO5 ‐related myopathy. Annals Of Clinical And Translational Neurology, [S.L.], v. 6, n. 7, p. 1225-1238, 11 jun. 2019. Wiley. http://dx.doi.org/10.1002/acn3.50801. Disponível em: https://onlinelibrary.wiley.com/doi/10.1002/acn3.50801. Acesso em: 18 jul. 2023.https://repositorio.ufrn.br/handle/123456789/54227https://doi.org/10.1002/acn3.50801Wileyhttps://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessmyopathycohort of ANO5-relatedmiopatia relacionada ao ANO5Clinical and molecular findings in a cohort of ANO5-related myopathyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleObjective:ANO5-related myopathy is an important cause of limb-girdle muscu-lar dystrophy (LGMD) and hyperCKemia. The main descriptions have emergedfrom European cohorts, and the burden of the disease worldwide is unclear. Weprovide a detailed characterization of a large Brazilian cohort fANO5patients.Methods: A national cross-sectional study was conducted to describe clinical,histopathological, radiological, and molecular features of patients carrying reces-sive variants inANO5. Correlation of clinical and genetic characteristics with dif-ferent phenotypes was studied.Results: Thirty-seven patients from 34 nonrelatedfamilies with recessive mutations ofANO5were identified. The most commonphenotype was LGMD, observed in 25 (67.5%) patients, followed by pseu-dometabolic presentation in 7 (18.9%) patients, isolated asymptomatic hyperCK-emia in 4 (10.8%) patients, and distal myopathy in a single patient. Nine patientspresented axial involvement, including one patient with isolated axial weakness.The most affected muscles according to MRI were the semimembranosus and gas-trocnemius, but paraspinal and abdominal muscles, when studied, were involved in most patients. Fourteen variants inANO5were identified, and the c.191dupAwas present in 19 (56%) families. Sex, years of disease, and the presence of loss-of-function variants were not associated with specific phenotypes.Interpretation:We present the largest series of anoctaminopathy outside Europe. The most com-mon European founder mutation c.191dupA was very frequent in our population.Gender, disease duration, and genotype did not determine the phenotype.engreponame:Repositório Institucional da UFRNinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNLICENSElicense.txtlicense.txttext/plain; charset=utf-81484https://repositorio.ufrn.br/bitstream/123456789/54227/2/license.txte9597aa2854d128fd968be5edc8a28d9MD52ORIGINALClinicalMolecularFindings_DouradoJr_2019.pdfClinicalMolecularFindings_DouradoJr_2019.pdfapplication/pdf1818692https://repositorio.ufrn.br/bitstream/123456789/54227/1/ClinicalMolecularFindings_DouradoJr_2019.pdf77860e9af50bb6f45a715e002d9c4761MD51123456789/542272023-07-27 15:25:24.134oai:https://repositorio.ufrn.br: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Repositório de PublicaçõesPUBhttp://repositorio.ufrn.br/oai/opendoar:2023-07-27T18:25:24Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)false
dc.title.pt_BR.fl_str_mv Clinical and molecular findings in a cohort of ANO5-related myopathy
title Clinical and molecular findings in a cohort of ANO5-related myopathy
spellingShingle Clinical and molecular findings in a cohort of ANO5-related myopathy
Dourado Junior, Mário Emílio Teixeira
myopathy
cohort of ANO5-related
miopatia relacionada ao ANO5
title_short Clinical and molecular findings in a cohort of ANO5-related myopathy
title_full Clinical and molecular findings in a cohort of ANO5-related myopathy
title_fullStr Clinical and molecular findings in a cohort of ANO5-related myopathy
title_full_unstemmed Clinical and molecular findings in a cohort of ANO5-related myopathy
title_sort Clinical and molecular findings in a cohort of ANO5-related myopathy
author Dourado Junior, Mário Emílio Teixeira
author_facet Dourado Junior, Mário Emílio Teixeira
Silva, André M. S.
Coimbra-Neto, Antônio R.; et al.
author_role author
author2 Silva, André M. S.
Coimbra-Neto, Antônio R.; et al.
author2_role author
author
dc.contributor.authorID.pt_BR.fl_str_mv https://orcid.org/0000-0002-9462-2294
dc.contributor.author.fl_str_mv Dourado Junior, Mário Emílio Teixeira
Silva, André M. S.
Coimbra-Neto, Antônio R.; et al.
dc.subject.por.fl_str_mv myopathy
cohort of ANO5-related
miopatia relacionada ao ANO5
topic myopathy
cohort of ANO5-related
miopatia relacionada ao ANO5
description Objective:ANO5-related myopathy is an important cause of limb-girdle muscu-lar dystrophy (LGMD) and hyperCKemia. The main descriptions have emergedfrom European cohorts, and the burden of the disease worldwide is unclear. Weprovide a detailed characterization of a large Brazilian cohort fANO5patients.Methods: A national cross-sectional study was conducted to describe clinical,histopathological, radiological, and molecular features of patients carrying reces-sive variants inANO5. Correlation of clinical and genetic characteristics with dif-ferent phenotypes was studied.Results: Thirty-seven patients from 34 nonrelatedfamilies with recessive mutations ofANO5were identified. The most commonphenotype was LGMD, observed in 25 (67.5%) patients, followed by pseu-dometabolic presentation in 7 (18.9%) patients, isolated asymptomatic hyperCK-emia in 4 (10.8%) patients, and distal myopathy in a single patient. Nine patientspresented axial involvement, including one patient with isolated axial weakness.The most affected muscles according to MRI were the semimembranosus and gas-trocnemius, but paraspinal and abdominal muscles, when studied, were involved in most patients. Fourteen variants inANO5were identified, and the c.191dupAwas present in 19 (56%) families. Sex, years of disease, and the presence of loss-of-function variants were not associated with specific phenotypes.Interpretation:We present the largest series of anoctaminopathy outside Europe. The most com-mon European founder mutation c.191dupA was very frequent in our population.Gender, disease duration, and genotype did not determine the phenotype.
publishDate 2019
dc.date.issued.fl_str_mv 2019
dc.date.accessioned.fl_str_mv 2023-07-27T18:17:20Z
dc.date.available.fl_str_mv 2023-07-27T18:17:20Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv DOURADO JUNIOR, Mário Emílio Teixeira, et al. Clinical and molecular findings in a cohort of ANO5 ‐related myopathy. Annals Of Clinical And Translational Neurology, [S.L.], v. 6, n. 7, p. 1225-1238, 11 jun. 2019. Wiley. http://dx.doi.org/10.1002/acn3.50801. Disponível em: https://onlinelibrary.wiley.com/doi/10.1002/acn3.50801. Acesso em: 18 jul. 2023.
dc.identifier.uri.fl_str_mv https://repositorio.ufrn.br/handle/123456789/54227
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1002/acn3.50801
identifier_str_mv DOURADO JUNIOR, Mário Emílio Teixeira, et al. Clinical and molecular findings in a cohort of ANO5 ‐related myopathy. Annals Of Clinical And Translational Neurology, [S.L.], v. 6, n. 7, p. 1225-1238, 11 jun. 2019. Wiley. http://dx.doi.org/10.1002/acn3.50801. Disponível em: https://onlinelibrary.wiley.com/doi/10.1002/acn3.50801. Acesso em: 18 jul. 2023.
url https://repositorio.ufrn.br/handle/123456789/54227
https://doi.org/10.1002/acn3.50801
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRN
instname:Universidade Federal do Rio Grande do Norte (UFRN)
instacron:UFRN
instname_str Universidade Federal do Rio Grande do Norte (UFRN)
instacron_str UFRN
institution UFRN
reponame_str Repositório Institucional da UFRN
collection Repositório Institucional da UFRN
bitstream.url.fl_str_mv https://repositorio.ufrn.br/bitstream/123456789/54227/2/license.txt
https://repositorio.ufrn.br/bitstream/123456789/54227/1/ClinicalMolecularFindings_DouradoJr_2019.pdf
bitstream.checksum.fl_str_mv e9597aa2854d128fd968be5edc8a28d9
77860e9af50bb6f45a715e002d9c4761
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)
repository.mail.fl_str_mv
_version_ 1802117607931772928